Abstract:Background: Aging has long been thought to be a major risk factor for various types of cancers. However, accumulating evidence indicates increased resistance of old animals to tumor growth. An in-depth understanding of how old individuals defend against tumor invasion requires further investigations. Methods: We revealed age-associated alterations in tumor-infiltrating immune cells between young and old mice using single-cell RNA and coupled T cell receptor (TCR) sequencing analysis. Multiple bioinformatics methods were adopted to analyze the characteristics of the transcriptome between two groups. To explore the impacts of young and old CD8+ T cells on tumor growth, mice were treated with anti-CD8 antibody every 3 days starting 7 days after tumor inoculation. Flow cytometry was used to validate the differences indicated by sequencing analysis between young and old mice. Results: We found a higher proportion of cytotoxic CD8+ T cells, naturally occurring Tregs, conventional dendritic cell (DC), and M1-like macrophages in tumors of old mice compared with a higher percentage of exhausted CD8+ T cells, induced Tregs, plasmacytoid DC, and M2-like macrophages in young mice. Importantly, TCR diversity analysis showed that top 10 TCR clones consisted primarily of exhausted CD8+ T cells in young mice whereas top clones were predominantly cytotoxic CD8+ T cells in old mice. Old mice had more CD8+ T cells with a 'progenitor' and less 'terminally' exhausted phenotypes than young mice. Consistently, trajectory inference demonstrated that CD8+ T cells preferentially differentiated into cytotoxic cells in old mice in contrast to exhausted cells in young mice. Importantly, elimination of CD8+ T cells in old mice during tumor growth significantly accelerated tumor development. Moreover, senescent features were demonstrated in exhausted but not cytotoxic CD8+ T cells regardless of young and old mice. Conclusions: Our data revealed that a significantly higher proportion of effector immune cells in old mice defends against tumor progression, providing insights into understanding the altered kinetics of cancer development and the differential response to immunotherapeutic modulation in elderly patients.

Age-Related Gene Alteration in Naïve and Memory T Cells Using Precise Age-Tracking Model

Age-Related Immune Profile of the T Cell Receptor Repertoire, Thymic Recent Output Function, and Mirnas

Age Related Human Memory T Cell Subset Evolution and Senescence

Quantifiable Blood TCR Repertoire Components Associated with Immune Aging

Quantifiable blood TCR repertoire components associate with immune aging

Functional pathways regulated by microRNA networks in CD8 T-cell aging

Single-cell sequencing characterizes intratumoral profile of immune cells in old mice

Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice

Changes Of Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells In Aged Balb/C Mice

Heterogeneity and transcriptome changes of human CD8+ T cells across nine decades of life

Aging trajectories of memory CD8+ T cells differ by their antigen specificity

Biologically informed machine learning modeling of immune cells to reveal physiological and pathological aging process

Distinct epigenomes in CD4 + T cells of newborns, middle-ages and centenarians

Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK+ CD8+ T Cells as Conserved Hallmark of Inflammaging

Gene Regulatory Programs that Specify Age-Related Differences during Thymocyte Development

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Age-related Changes in Phenotypes of T Lymphocytes in Human Peripheral Blood

Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy Adults

The influences of age on T lymphocyte subsets in C57BL/6 mice.

Conserved epigenetic hallmarks of T cell aging during immunity and malignancy